KIMBERLY SILVA: Open Payments
NPI 1568203438 · NAUGATUCK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $39 |
| Novo Nordisk Inc | 1 | $31 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Astellas Pharma US Inc | 1 | $29 |
| Exact Sciences Corporation | 1 | $25 |
| Intra-Sana Laboratories | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: FANAPT, Wegovy, JOURNAVX, Veozah, The Cologuard Plus Collection Kit, RELTONE 200 MG, FARXIGA.
Industry payments across CT — which companies pay providers there.
